Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2023-06-05 00:00:00 ET · period of report 2023-06-01 · accession 0001628280-23-020841 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-05 | 2023-06-01 | LFCR | Hall James G | CEO, Dir | A - Grant | — | +225.0K | 201.1K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-01 | A | A | 75,000 | — | 276,096 | D | — | — | (F3) Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control. (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Common | Common Stock | 2023-06-01 | A | A | 150,000 | — | 201,096 | D | — | — | (F2) Restricted Stock Units will vest on the 3rd anniversary of the grant date. (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |